ReP USP - Resultado da busca

Artigo de periodico
Hyperinsulinemic-euglycemic clamp strengthens the insulin resistance in nonclassical congenital adrenal hyperplasia (2022)
Delai, Ariane; Gomes, Patrícia M.; Foss-Freitas, Maria Cristina ; Elias Júnior, Jorge ; Antonini, Sonir Roberto Rauber ; Castro, Margaret de ; Moreira, Ayrton Custódio ; Mermejo, Lívia Mara
Fonte: The Journal of Clinical Endocrinology and Metabolism. Unidade: FMRP
Assuntos: GENÓTIPOS, RESISTÊNCIA À INSULINA, HIPERPLASIAS, HIPERPLASIA SUPRARRENAL CONGÊNITA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DELAI, Ariane et al. Hyperinsulinemic-euglycemic clamp strengthens the insulin resistance in nonclassical congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism, v. 107, n. 3, p. e1106-e1116, 2022Tradução . . Disponível em: https://doi.org/10.1210/clinem/dgab767. Acesso em: 18 nov. 2024.
APA
Delai, A., Gomes, P. M., Foss-Freitas, M. C., Elias Júnior, J., Antonini, S. R. R., Castro, M. de, et al. (2022). Hyperinsulinemic-euglycemic clamp strengthens the insulin resistance in nonclassical congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism, 107( 3), e1106-e1116. doi:10.1210/clinem/dgab767
NLM
Delai A, Gomes PM, Foss-Freitas MC, Elias Júnior J, Antonini SRR, Castro M de, Moreira AC, Mermejo LM. Hyperinsulinemic-euglycemic clamp strengthens the insulin resistance in nonclassical congenital adrenal hyperplasia [Internet]. The Journal of Clinical Endocrinology and Metabolism. 2022 ; 107( 3): e1106-e1116.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1210/clinem/dgab767
Vancouver
Delai A, Gomes PM, Foss-Freitas MC, Elias Júnior J, Antonini SRR, Castro M de, Moreira AC, Mermejo LM. Hyperinsulinemic-euglycemic clamp strengthens the insulin resistance in nonclassical congenital adrenal hyperplasia [Internet]. The Journal of Clinical Endocrinology and Metabolism. 2022 ; 107( 3): e1106-e1116.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1210/clinem/dgab767
Artigo de periodico
Integrating methylome and transcriptome signatures expands the molecular classification of the pituitary tumors (2022)
Silva Júnior, Rui Milton Patrício da; Bueno, Ana Carolina; Martins, Clarissa Silva; Coelli-Lacchini, Fernanda; Ozaki, Jorge Guilherme Okanobo; Almeida-e-Silva, Danillo Cunha de ; Marrero-Gutiérrez, Junier; Santos, Antônio Carlos dos; Garcia-Peral, Carlos; Machado, Hélio Rubens; Santos, Marcelo Volpon ; Elias, Paula Conde Lamparelli; Moreira, Ayrton Custódio; Colli, Leandro Machado ; Vêncio, Ricardo Zorzetto Nicoliello; Antonini, Sonir Roberto Rauber ; Castro, Margaret de
Fonte: Journal of Clinical Endocrinology and Metabolism. Unidades: FMRP, FFCLRP, BIOINFORMÁTICA
Assuntos: NEOPLASIAS HIPOFISÁRIAS, METILAÇÃO DE DNA, SEQUENCIAMENTO GENÉTICO, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA JÚNIOR, Rui Milton Patrício da et al. Integrating methylome and transcriptome signatures expands the molecular classification of the pituitary tumors. Journal of Clinical Endocrinology and Metabolism, v. 108, n. 6, p. 1452-1463, 2022Tradução . . Disponível em: https://doi.org/10.1210/clinem/dgac703. Acesso em: 18 nov. 2024.
APA
Silva Júnior, R. M. P. da, Bueno, A. C., Martins, C. S., Coelli-Lacchini, F., Ozaki, J. G. O., Almeida-e-Silva, D. C. de, et al. (2022). Integrating methylome and transcriptome signatures expands the molecular classification of the pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 108( 6), 1452-1463. doi:10.1210/clinem/dgac703
NLM
Silva Júnior RMP da, Bueno AC, Martins CS, Coelli-Lacchini F, Ozaki JGO, Almeida-e-Silva DC de, Marrero-Gutiérrez J, Santos AC dos, Garcia-Peral C, Machado HR, Santos MV, Elias PCL, Moreira AC, Colli LM, Vêncio RZN, Antonini SRR, Castro M de. Integrating methylome and transcriptome signatures expands the molecular classification of the pituitary tumors [Internet]. Journal of Clinical Endocrinology and Metabolism. 2022 ; 108( 6): 1452-1463.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1210/clinem/dgac703
Vancouver
Silva Júnior RMP da, Bueno AC, Martins CS, Coelli-Lacchini F, Ozaki JGO, Almeida-e-Silva DC de, Marrero-Gutiérrez J, Santos AC dos, Garcia-Peral C, Machado HR, Santos MV, Elias PCL, Moreira AC, Colli LM, Vêncio RZN, Antonini SRR, Castro M de. Integrating methylome and transcriptome signatures expands the molecular classification of the pituitary tumors [Internet]. Journal of Clinical Endocrinology and Metabolism. 2022 ; 108( 6): 1452-1463.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1210/clinem/dgac703
Artigo de periodico
Adult height in 299 patients with Turner syndrome with or without growth hormone therapy: results and literature review (2021)
Dantas, Naiara Castelo Branco; Braz, Adriana F.; Malaquias, Alexsandra; Lemos-Marini, Sofia; Arnhold, Ivo Jorge Prado ; Ramos, Ester Silveira; Antonini, Sonir Roberto Rauber ; Guerra-Junior, Gil; Mendonça, Berenice Bilharinho de; Jorge, Alexander Augusto de Lima ; Scalco, Renata C.
Fonte: Hormone Research in Paediatrics. Unidades: FM, FMRP
Assuntos: HORMÔNIO DO CRESCIMENTO, ADULTOS, HORMÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANTAS, Naiara Castelo Branco et al. Adult height in 299 patients with Turner syndrome with or without growth hormone therapy: results and literature review. Hormone Research in Paediatrics, v. 94, n. 1-2, p. 63-70, 2021Tradução . . Disponível em: https://doi.org/10.1159/000516869. Acesso em: 18 nov. 2024.
APA
Dantas, N. C. B., Braz, A. F., Malaquias, A., Lemos-Marini, S., Arnhold, I. J. P., Ramos, E. S., et al. (2021). Adult height in 299 patients with Turner syndrome with or without growth hormone therapy: results and literature review. Hormone Research in Paediatrics, 94( 1-2), 63-70. doi:10.1159/000516869
NLM
Dantas NCB, Braz AF, Malaquias A, Lemos-Marini S, Arnhold IJP, Ramos ES, Antonini SRR, Guerra-Junior G, Mendonça BB de, Jorge AA de L, Scalco RC. Adult height in 299 patients with Turner syndrome with or without growth hormone therapy: results and literature review [Internet]. Hormone Research in Paediatrics. 2021 ; 94( 1-2): 63-70.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1159/000516869
Vancouver
Dantas NCB, Braz AF, Malaquias A, Lemos-Marini S, Arnhold IJP, Ramos ES, Antonini SRR, Guerra-Junior G, Mendonça BB de, Jorge AA de L, Scalco RC. Adult height in 299 patients with Turner syndrome with or without growth hormone therapy: results and literature review [Internet]. Hormone Research in Paediatrics. 2021 ; 94( 1-2): 63-70.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1159/000516869
Artigo de periodico
Pde8b haploinsufficiency in mice is associated with modest adrenal defects, impaired steroidogenesis, and male infertility, unaltered by concurrent PKA or Wnt activation (2021)
Leal, Leticia Ferro; Szarek, Eva; Berthon, Annabel; Nesterova, Maria; Faucz, Fabio R; London, Edra; Mercier, Christopher; Abu-Asab, Mones; Starost, Matthew F; Dye, Louis; Bilinska, Barbara; Kotula-Balak, Malgorzata; Antonini, Sonir Roberto Rauber ; Stratakis, Constantine A
Fonte: Molecular and Cellular Endocrinology. Unidade: FMRP
Assuntos: TRANSDUÇÃO DE SINAL CELULAR, GLÂNDULAS SUPRARRENAIS, ALDOSTERONA, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, CRUZAMENTOS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Leticia Ferro et al. Pde8b haploinsufficiency in mice is associated with modest adrenal defects, impaired steroidogenesis, and male infertility, unaltered by concurrent PKA or Wnt activation. Molecular and Cellular Endocrinology, v. 15, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.mce.2020.111117. Acesso em: 18 nov. 2024.
APA
Leal, L. F., Szarek, E., Berthon, A., Nesterova, M., Faucz, F. R., London, E., et al. (2021). Pde8b haploinsufficiency in mice is associated with modest adrenal defects, impaired steroidogenesis, and male infertility, unaltered by concurrent PKA or Wnt activation. Molecular and Cellular Endocrinology, 15. doi:10.1016/j.mce.2020.111117
NLM
Leal LF, Szarek E, Berthon A, Nesterova M, Faucz FR, London E, Mercier C, Abu-Asab M, Starost MF, Dye L, Bilinska B, Kotula-Balak M, Antonini SRR, Stratakis CA. Pde8b haploinsufficiency in mice is associated with modest adrenal defects, impaired steroidogenesis, and male infertility, unaltered by concurrent PKA or Wnt activation [Internet]. Molecular and Cellular Endocrinology. 2021 ; 15[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.mce.2020.111117
Vancouver
Leal LF, Szarek E, Berthon A, Nesterova M, Faucz FR, London E, Mercier C, Abu-Asab M, Starost MF, Dye L, Bilinska B, Kotula-Balak M, Antonini SRR, Stratakis CA. Pde8b haploinsufficiency in mice is associated with modest adrenal defects, impaired steroidogenesis, and male infertility, unaltered by concurrent PKA or Wnt activation [Internet]. Molecular and Cellular Endocrinology. 2021 ; 15[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.mce.2020.111117
Artigo de periodico
Clinical, molecular, functional, and structural characterization of CYP17A1 mutations in brazilian patients with 17-hydroxylase deficiency (2020)
Coeli-Lacchini, Fernanda Borchers ; Mermejo, Livia M.; Bodoni, Aline Faccioli; Elias, Lucila Leico Kagohara ; Silva Junior, Wilson Araújo da ; Antonini, Sonir Roberto Rauber ; Moreira, Ayrton Custódio ; Castro, Margaret de
Fonte: Hormone and Metabolic Research. Unidade: FMRP
Assuntos: HIPERPLASIAS, SEQUÊNCIA DE AMINOÁCIDOS, SEQUÊNCIA DE BASES, HORMÔNIOS, ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELI-LACCHINI, Fernanda Borchers et al. Clinical, molecular, functional, and structural characterization of CYP17A1 mutations in brazilian patients with 17-hydroxylase deficiency. Hormone and Metabolic Research, v. 52, n. 3, p. 186-193, 2020Tradução . . Disponível em: https://doi.org/10.1055/a-1100-7066. Acesso em: 18 nov. 2024.
APA
Coeli-Lacchini, F. B., Mermejo, L. M., Bodoni, A. F., Elias, L. L. K., Silva Junior, W. A. da, Antonini, S. R. R., et al. (2020). Clinical, molecular, functional, and structural characterization of CYP17A1 mutations in brazilian patients with 17-hydroxylase deficiency. Hormone and Metabolic Research, 52( 3), 186-193. doi:10.1055/a-1100-7066
NLM
Coeli-Lacchini FB, Mermejo LM, Bodoni AF, Elias LLK, Silva Junior WA da, Antonini SRR, Moreira AC, Castro M de. Clinical, molecular, functional, and structural characterization of CYP17A1 mutations in brazilian patients with 17-hydroxylase deficiency [Internet]. Hormone and Metabolic Research. 2020 ; 52( 3): 186-193.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1055/a-1100-7066
Vancouver
Coeli-Lacchini FB, Mermejo LM, Bodoni AF, Elias LLK, Silva Junior WA da, Antonini SRR, Moreira AC, Castro M de. Clinical, molecular, functional, and structural characterization of CYP17A1 mutations in brazilian patients with 17-hydroxylase deficiency [Internet]. Hormone and Metabolic Research. 2020 ; 52( 3): 186-193.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1055/a-1100-7066
Artigo de periodico
Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas (2018)
Jucá, Carlos Eduardo Barros; Colli, Leandro Machado; Martins, Clarissa Silva; Campanini, Marina Lanciotti; Paixão, Beatriz; Jucá, Renata Viana; Saggioro, Fabiano Pinto; Oliveira, Ricardo Santos de; Moreira, Ayrton Custódio; Machado, Hélio Rubens; Neder, Luciano; Antonini, Sonir Roberto Rauber; Castro, Margaret de
Fonte: Hormone and Metabolic Research. Unidades: FMRP, SVOI
Assuntos: NEOPLASIAS CEREBRAIS, GLÂNDULA PITUITÁRIA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JUCÁ, Carlos Eduardo Barros et al. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Hormone and Metabolic Research, v. 50, n. 7, p. 575-581, 2018Tradução . . Disponível em: https://doi.org/10.1055/a-0593-5956. Acesso em: 18 nov. 2024.
APA
Jucá, C. E. B., Colli, L. M., Martins, C. S., Campanini, M. L., Paixão, B., Jucá, R. V., et al. (2018). Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Hormone and Metabolic Research, 50( 7), 575-581. doi:10.1055/a-0593-5956
NLM
Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, Oliveira RS de, Moreira AC, Machado HR, Neder L, Antonini SRR, Castro M de. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas [Internet]. Hormone and Metabolic Research. 2018 ; 50( 7): 575-581.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1055/a-0593-5956
Vancouver
Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, Oliveira RS de, Moreira AC, Machado HR, Neder L, Antonini SRR, Castro M de. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas [Internet]. Hormone and Metabolic Research. 2018 ; 50( 7): 575-581.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1055/a-0593-5956
Artigo de periodico
The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line (2017)
Borges, Kleiton S.; Andrade, Augusto F.; Silveira, Vanessa da Silva; Marco Antonio, David S.; Vasconcelos, Elton J.R.; Antonini, Sonir Roberto Rauber; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Anti-Cancer Drugs. Unidade: FMRP
Assuntos: APOPTOSE, FÁRMACOS, ANTINEOPLÁSICOS, CARCINOMA, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Kleiton S. et al. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line. Anti-Cancer Drugs, v. 28, n. 6, p. 634-644, 2017Tradução . . Disponível em: https://doi.org/10.1097/cad.0000000000000504. Acesso em: 18 nov. 2024.
APA
Borges, K. S., Andrade, A. F., Silveira, V. da S., Marco Antonio, D. S., Vasconcelos, E. J. R., Antonini, S. R. R., et al. (2017). The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line. Anti-Cancer Drugs, 28( 6), 634-644. doi:10.1097/cad.0000000000000504
NLM
Borges KS, Andrade AF, Silveira V da S, Marco Antonio DS, Vasconcelos EJR, Antonini SRR, Tone LG, Scrideli CA. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line [Internet]. Anti-Cancer Drugs. 2017 ; 28( 6): 634-644.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1097/cad.0000000000000504
Vancouver
Borges KS, Andrade AF, Silveira V da S, Marco Antonio DS, Vasconcelos EJR, Antonini SRR, Tone LG, Scrideli CA. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line [Internet]. Anti-Cancer Drugs. 2017 ; 28( 6): 634-644.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1097/cad.0000000000000504
Artigo de periodico
New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro (2016)
Pileggi, Gecilmara Salviato; Clemencio, Aline Dayana; Malardo, Thiago; Antonini, Sonir Roberto Rauber; Bonato, Vânia Luiza Deperon; Rios, Wendy Martin; Silva, Célio Lopes
Fonte: BMC Biotechnology. Unidade: FMRP
Assuntos: IMUNOTERAPIA, DIABETES MELLITUS, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PILEGGI, Gecilmara Salviato et al. New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro. BMC Biotechnology, v. 16, n. 1, 2016Tradução . . Disponível em: https://doi.org/10.1186/s12896-016-0270-0. Acesso em: 18 nov. 2024.
APA
Pileggi, G. S., Clemencio, A. D., Malardo, T., Antonini, S. R. R., Bonato, V. L. D., Rios, W. M., & Silva, C. L. (2016). New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro. BMC Biotechnology, 16( 1). doi:10.1186/s12896-016-0270-0
NLM
Pileggi GS, Clemencio AD, Malardo T, Antonini SRR, Bonato VLD, Rios WM, Silva CL. New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro [Internet]. BMC Biotechnology. 2016 ; 16( 1):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12896-016-0270-0
Vancouver
Pileggi GS, Clemencio AD, Malardo T, Antonini SRR, Bonato VLD, Rios WM, Silva CL. New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro [Internet]. BMC Biotechnology. 2016 ; 16( 1):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12896-016-0270-0
Artigo de periodico
Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis (2015)
Leal, Letícia F; Bueno, Ana Carolina; Gomes, Débora C; Abduch, Rafael; Castro, Margaret de; Antonini, Sonir Roberto Rauber
Fonte: Oncotarget. Unidade: FMRP
Assuntos: NEOPLASIAS, APOPTOSE, TERAPÊUTICA MÉDICA, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Letícia F et al. Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis. Oncotarget, v. 6, n. 40, p. 43016-43032, 2015Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.5513. Acesso em: 18 nov. 2024.
APA
Leal, L. F., Bueno, A. C., Gomes, D. C., Abduch, R., Castro, M. de, & Antonini, S. R. R. (2015). Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis. Oncotarget, 6( 40), 43016-43032. doi:10.18632/oncotarget.5513
NLM
Leal LF, Bueno AC, Gomes DC, Abduch R, Castro M de, Antonini SRR. Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis [Internet]. Oncotarget. 2015 ; 6( 40): 43016-43032.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.5513
Vancouver
Leal LF, Bueno AC, Gomes DC, Abduch R, Castro M de, Antonini SRR. Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis [Internet]. Oncotarget. 2015 ; 6( 40): 43016-43032.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.5513
Artigo de periodico
Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) (2014)
Leite, Fabíola A; Lira, Régia C. P; Fedatto, Paola F; Antonini, Sonir Roberto Rauber; Martinelli Junior, Carlos Eduardo; Castro, Margaret de; Neder, Luciano; Ramalho, Leandra Naíra Zambelli; Tucci Júnior, Silvio; Mastelaro, Maria J; Seidinger, Ana L; Cardinalli, Izilda A; Yunes, José A; Brandalise, Silvia R; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Pediatric Blood and Cancer. Unidade: FMRP
Assuntos: NEOPLASIAS DO CÓRTEX SUPRARRENAL, CRIANÇAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Fabíola A et al. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT). Pediatric Blood and Cancer, v. 61, n. 11, p. 1940-1948, 2014Tradução . . Disponível em: https://doi.org/10.1002/pbc.25118. Acesso em: 18 nov. 2024.
APA
Leite, F. A., Lira, R. C. P., Fedatto, P. F., Antonini, S. R. R., Martinelli Junior, C. E., Castro, M. de, et al. (2014). Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT). Pediatric Blood and Cancer, 61( 11), 1940-1948. doi:10.1002/pbc.25118
NLM
Leite FA, Lira RCP, Fedatto PF, Antonini SRR, Martinelli Junior CE, Castro M de, Neder L, Ramalho LNZ, Tucci Júnior S, Mastelaro MJ, Seidinger AL, Cardinalli IA, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) [Internet]. Pediatric Blood and Cancer. 2014 ; 61( 11): 1940-1948.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/pbc.25118
Vancouver
Leite FA, Lira RCP, Fedatto PF, Antonini SRR, Martinelli Junior CE, Castro M de, Neder L, Ramalho LNZ, Tucci Júnior S, Mastelaro MJ, Seidinger AL, Cardinalli IA, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) [Internet]. Pediatric Blood and Cancer. 2014 ; 61( 11): 1940-1948.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/pbc.25118
Artigo de periodico
Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels (2010)
Fernandes Rosa, F. L.; Bueno, A. C.; Souza, R. Molina de; Castro, Margaret de; Santos, Jose Ernesto dos; Foss, Milton César; Zennaro, M. -C.; Bettiol, Heloisa; Barbieri, Marco Antonio; Antonini, Sonir Roberto Rauber
Fonte: Journal of Endocrinological Investigation. Unidade: FMRP
Assuntos: HIPERTENSÃO, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES ROSA, F. L. et al. Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels. Journal of Endocrinological Investigation, v. 33, n. 7, p. 472-477, 2010Tradução . . Disponível em: https://doi.org/10.1007/bf03346627. Acesso em: 18 nov. 2024.
APA
Fernandes Rosa, F. L., Bueno, A. C., Souza, R. M. de, Castro, M. de, Santos, J. E. dos, Foss, M. C., et al. (2010). Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels. Journal of Endocrinological Investigation, 33( 7), 472-477. doi:10.1007/bf03346627
NLM
Fernandes Rosa FL, Bueno AC, Souza RM de, Castro M de, Santos JE dos, Foss MC, Zennaro M-C, Bettiol H, Barbieri MA, Antonini SRR. Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels [Internet]. Journal of Endocrinological Investigation. 2010 ; 33( 7): 472-477.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/bf03346627
Vancouver
Fernandes Rosa FL, Bueno AC, Souza RM de, Castro M de, Santos JE dos, Foss MC, Zennaro M-C, Bettiol H, Barbieri MA, Antonini SRR. Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels [Internet]. Journal of Endocrinological Investigation. 2010 ; 33( 7): 472-477.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/bf03346627
Artigo de periodico
Adiponectin: serum levels, promoter polymorphism, and associations with birth size and cardiometabolic outcome in young adults born large for gestational age (2010)
Bueno, Ana Carolina; Espiñeira, Aniette R.; Fernandes-Rosa, Fábio L.; Souza, Roberto Molina de; Castro, Margaret de; Moreira, Ayrton Custódio; Bettiol, Heloisa; Barbieri, Marco Antonio; Antonini, Sonir Roberto Rauber
Fonte: European Journal of Endocrinology. Unidade: FMRP
Assuntos: POLIMORFISMO, BEBÊS, ADIPONECTINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Ana Carolina et al. Adiponectin: serum levels, promoter polymorphism, and associations with birth size and cardiometabolic outcome in young adults born large for gestational age. European Journal of Endocrinology, v. 162, n. 1, p. 53-60, 2010Tradução . . Disponível em: https://doi.org/10.1530/eje-09-0697. Acesso em: 18 nov. 2024.
APA
Bueno, A. C., Espiñeira, A. R., Fernandes-Rosa, F. L., Souza, R. M. de, Castro, M. de, Moreira, A. C., et al. (2010). Adiponectin: serum levels, promoter polymorphism, and associations with birth size and cardiometabolic outcome in young adults born large for gestational age. European Journal of Endocrinology, 162( 1), 53-60. doi:10.1530/eje-09-0697
NLM
Bueno AC, Espiñeira AR, Fernandes-Rosa FL, Souza RM de, Castro M de, Moreira AC, Bettiol H, Barbieri MA, Antonini SRR. Adiponectin: serum levels, promoter polymorphism, and associations with birth size and cardiometabolic outcome in young adults born large for gestational age [Internet]. European Journal of Endocrinology. 2010 ; 162( 1): 53-60.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1530/eje-09-0697
Vancouver
Bueno AC, Espiñeira AR, Fernandes-Rosa FL, Souza RM de, Castro M de, Moreira AC, Bettiol H, Barbieri MA, Antonini SRR. Adiponectin: serum levels, promoter polymorphism, and associations with birth size and cardiometabolic outcome in young adults born large for gestational age [Internet]. European Journal of Endocrinology. 2010 ; 162( 1): 53-60.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1530/eje-09-0697

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada